https://charts.traderzeitung.de/phases/US86150R1077 string(1478) "{"isin":"US86150R1077","name":"Stoke Therapeutics Inc","stock_id_xnas":9332476,"stock_id_xnys":9332470,"generated_at":"2026-08-09 08:03:00","days":[{"date":"2026-08-05","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":32.44,"close_at":"2026-08-05 15:28:00","complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":31.95,"close_at":"2026-08-05 21:59:00","complete":true,"perf_pct":-1.5105},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":31.95,"close_at":"2026-08-05 22:00:00","complete":true,"perf_pct":0}]},{"date":"2026-08-06","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":32.05,"close_at":"2026-08-06 14:00:00","complete":true,"perf_pct":0.313},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":31.895,"close_at":"2026-08-06 21:59:00","complete":true,"perf_pct":-0.4836},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-08-07","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":31.61,"close_at":"2026-08-07 14:06:00","complete":true,"perf_pct":-0.8936},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":32.68,"close_at":"2026-08-07 21:59:00","complete":true,"perf_pct":3.385},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"

Stoke Therapeutics Aktie News & Nachrichten

[WKN: A2PLTL | Symbol: STOK]

Realtimekurs

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

10J

Alles

Artikel aus der Redaktion der Trader-Zeitung

05.02.2026 um 12 Uhr

Stoke Therapeutics

TOP-5-Kursziele der Analysten am 05.02.26

AppLovin [US03831W1080] Morgan Stanley bestätigt Buy-Rating mit Kursziel 800 USD (100 % Kurspotenzial)...

14.08.2025 um 13 Uhr

TOP-5-Kursziele der Analysten am 14.08.25

SimilarWeb [IL0011751653] Barclays bekräftigt Buy-Rating und erhöht das Kursziel von 10 auf...

18.07.2025 um 13 Uhr

TOP-5-Kursziele der Analysten am 18.07.25

Ambac Financial Group [US0231398845] Roth MKM bestätigt Buy-Rating mit Kursziel 15 USD (73 %...

Stoke Therapeutics Nachrichtenticker öffnen

MT Newswires 04.08.2026 14:19 Uhr

Goldman Sachs nimmt die Berichterstattung für Stoke Therapeutics mit einer Kaufempfehlung und einem Kursziel von 44 $ auf

MT Newswires 30.06.2026 15:48 Uhr

Stoke Therapeutics schließt Patientenrekrutierung in Phase-3-Studie von Zorevunersen zur Behandlung des Dravet-Syndroms ab

09:47 AM EDT, 06/30/2026 (MT Newswires) -- Stoke Therapeutics (STOK) teilte am Dienstag mit, die Rekrutierung von 162 Patienten für die Phase-3-Studie